The current status and future trends of BTK inhibitor for diffuse large B cell lymphoma
Saved in:
Main Authors: | Qiuni Chen (Author), Lei Xu (Author), Chuanyang Lu (Author), Chunling Wang (Author), Liang Yu (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combining BTK inhibitors with BCL2 inhibitors for treating chronic lymphocytic leukemia and mantle cell lymphoma
by: Jing Zhang, et al.
Published: (2022) -
Subcutaneous nodules in a patient with diffuse large B‐cell lymphoma
by: Benjamin Liang Jun Lui, et al.
Published: (2024) -
Current Perspectives: Evidence to Date on BTK Inhibitors in the Management of Multiple Sclerosis
by: Carnero Contentti E, et al.
Published: (2022) -
Composite lymphoma with coexistence of diffuse large B-cell lymphoma and anaplastic large cell lymphoma: Diagnostic pitfalls
by: Meyyappa Devan Rajagopal, et al.
Published: (2017) -
Primary diffuse large B-cell lymphoma of the mandible
by: Juliana Mota Siqueira, et al.
Published: (2019)